tag:blogger.com,1999:blog-35807323519060448072024-03-18T20:27:55.976-07:00Pharmaceutical Market Research ReportsAnonymoushttp://www.blogger.com/profile/17404765961249919111noreply@blogger.comBlogger106125tag:blogger.com,1999:blog-3580732351906044807.post-82414038818719588632016-03-04T05:29:00.002-08:002020-01-16T00:09:07.039-08:00Global Benign Prostatic Hyperplasia Therapeutics Market Growth Factor Effect On Awareness For Prostate Cancer <div dir="ltr" style="text-align: left;" trbidi="on">
Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections and urinary hesitancy.<br />
<b><br />Browse Complete Report: <a href="http://www.transparencymarketresearch.com/bph-therapeutics-market.html">http://www.transparencymarketresearch.com/bph-therapeutics-market.html</a></b><br />
<br />
<b>Some of the medical therapies used for the treatment of BPH are as follows:</b><br />
Alpha-Blockers<br />
5- Alpha-reductase inhibitors (5-ARIs)<br />
Alpha-Adrenergic Blockers<br />
Phosphodiesterase-5 Enzyme Inhibitors<br />
Anticholinergic Agents<br />
Nonselective alpha-blockers<br />
<br />
<b>Some of the surgical interventions used of the treatment of BPH are as follows:</b><br />
Holmium Laser Resection of the Prostate (HoLRP)<br />
Open prostatectomy<br />
Photoselective vaporization of the prostate (PVP)<br />
Transurethral holmium laser ablation of the prostate (HoLAP)<br />
Transurethral resection of the prostate (TURP)<br />
Transurethral vaporization of the prostate (TUVP)<br />
Transurethral incision of the prostate (TUIP)<br />
<br />
Geographically, North America is the leading market due to high prevalence rate of benign prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged between 45 and 80 years suffer from some type of LUTS and approximately 14 million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to witness a significant growth due to the rise in various urological disorders and complications. However, BPH tends to be more progressive in African-American men owing to the presence of high testosterone level in their body.<br />
<br />
Rise in geriatric population is expected to be one of the major driver that might drive the market. Additionally, increased awareness for prostate cancer and other urological disorders, are also expected to fuel the growth of the global BPH therapeutics market. However, high adoption rate of minimally invasive surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA) might impede the growth of the BPH therapeutics market.<br />
<br />
Some of the key players in the benign prostatic hyperplasia (BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.<br />
<br />
<b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1872">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1872</a><br /><br />About Us:-</b><br />
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br />
<b><br />Contact Us:-</b><br />
Mr.Sudip.S<br />
Transparency Market Research<br />
State Tower,<br />
90 State Street,<br />
Suite 700,<br />
Albany NY - 12207<br />
United States<br />
Tel: +1-518-618-1030<br />
Email: sales@transparencymarketresearch.com</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com1tag:blogger.com,1999:blog-3580732351906044807.post-1429743860699420902016-03-04T03:05:00.005-08:002016-03-04T03:05:45.713-08:00Upper Respiratory Tract Disorder Diagnostics and Therapeutics Market is expected to grow at a significant CAGR during the forecast period from 2014 to 2020 <div dir="ltr" style="text-align: left;" trbidi="on">
Respiratory disease is a medical condition that includes pathological conditions that affect tissues and organs which assist in making gas exchange possible in the organisms. Respiratory disease ranges from self-limiting and mild, such as the common cold, to life-threatening conditions such as lung cancer, pulmonary embolism and bacterial pneumonia. Various respiratory disease conditions include disorder of upper respiratory tract, bronchi, bronchioles, trachea, pleura and pleural cavity, alveoli, and the nerves and muscles of breathing.<br /><br /><b>Browse Full Report With Industry Expert Analysis: <a href="http://www.transparencymarketresearch.com/upper-respiratory-tract-disorder-diagnostics-therapeutics.html">http://www.transparencymarketresearch.com/upper-respiratory-tract-disorder-diagnostics-therapeutics.html</a></b><br /><br />Upper respiratory tract disorder or infection (URI or URTI) is a medical condition caused by acute infection that involves upper respiratory tract such as sinuses, nose, larynx or pharynx. Pharyngitis, tonsillitis, sinusitis, laryngitis, common cold, and otitis media are some of the most common upper respiratory tract disorders. Upper respiratory tract disorders are caused by direct invasion of the mucus membrane (inner respiratory tract lining) by bacteria or virus. Rhinorrhea, sneezing, nasal congestion, nasal discharge, sore throat, cough, fever, odynophagia and malaise are some of the most common symptoms observed in the patient diagnosed with upper respiratory tract disorder. Some other symptoms of the disease are headache, foul breath, hyposmia, sinus pain, shortness of breath, conjunctivitis, vomiting diarrhea, nausea, and body ache.<br /><br />Upper respiratory tract disorder can be diagnosed by physical examination, laboratory tests and review of symptoms. In physical examination, physicians look for redness and swollen inside the wall of nasal cavity, white secretions on the tonsils, redness of the eyes, redness of the throat, and enlarged lymph nodes around neck and head. Laboratory testing is usually not performed for examining upper respiratory tract disorders as most of the upper respiratory tract infections are caused by viruses and no specific treatment for different types of viral upper respiratory tract disorder is available in current scenario. Some of the laboratory tests that are performed for diagnosing upper respiratory tract disorder include imaging tests (X-ray and CT scan), blood tests and sputum tests.<br /><br />Upper respiratory tract disorders can be treated with antibiotics and decongestants. Acetaminophen, ibuprofen, diphenhydramine, dextromethorphan, codeine, guaifenesin, dexamethasone and prednisone are some of the antibiotics that are prescribed to the patients suffering from upper respiratory tract disorders. Oxymetazoline, phenylephrine and pseudoephedrine are some of the most commonly prescribed decongestants for the treatment of upper respiratory tract disorders. Antibiotics are rarely used as a treatment option for upper respiratory tract disorders as they are associated with many side effects and also can initiate secondary infections and bacterial resistance.<br /><br />The market for upper respiratory tract disorder diagnostics and therapeutics is expected to grow at a significant CAGR during the forecast period from 2014 to 2020 owing to increasing incidences of respiratory disorders across the globe. Similarly, constant changing climate condition due to global warming and pollution has further accentuated the risk for developing upper respiratory tract disorders. This in turn is expected to drive the growth of upper respiratory tract disorder diagnostics and therapeutics market. Currently, North America accounts for the largest share of the global upper respiratory tract disorder diagnostics and therapeutics market. This is due to the fact that the U.S. has witnessed for large patient pool suffering from upper respiratory tract disorders. <br /><br />Some of the major players operating in upper respiratory tract disorder diagnostics and therapeutics market include Alcon, Inc., Merck & Co., Inc., Collegium Pharmaceutical, Inc., GlaxoSmithKline plc and Verona Pharma Plc among other significant players across the globe.<br /><br />This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include <br />North America <br />Asia Pacific <br />Europe<br />Rest of the World <br /><br /><b>This report provides comprehensive analysis of </b><br />Market growth drivers <br />Factors limiting market growth<br />Current market trends <br />Market structure<br />Market projections for upcoming years <br /><br />This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. <br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3114">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3114</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-64160858541220328272016-03-03T05:54:00.002-08:002016-03-03T05:54:26.007-08:00Increasing Government Initiatives to Offer Better Healthcare Services to Fuel Growth of Medical Lifting Slings Market<div dir="ltr" style="text-align: left;" trbidi="on">
A patient lifting sling refers to an assistive device that assists patients in nursing homes and hospitals to be transferred between a chair and a bed or a similar resting place with the help of hydraulics. Medical lifting slings are used widely for patients whose mobility is limited. Apart from transferring, the sling lifts help in reducing the chance of orthopedic injury caused while lifting patients. Patient care mostly requires lifting or providing the means to perform movements to do day to day activities including toileting, walking, and bathing. Such tasks comprise handling of patients who are in a fragile condition. As a result, lifting patients becomes more risky and complicated. In addition, patients and residents may also have psychological, medical, or other related conditions, which can complicate manual lifting processes.<br /><br /><b>Browse Full Report With TOC: <a href="http://www.transparencymarketresearch.com/medical-lifting-slings-market.html">http://www.transparencymarketresearch.com/medical-lifting-slings-market.html</a><br /><br />Global Medical Lifting Slings Market to Register 7.80% CAGR from 2015 to 2023</b><br />The major factors that are fueling the growth of the global market for medical lifting slings include the now-aging baby boomer population, rental provisions for medical lifting sling devices that help in providing these products amongst lower-income groups, care provider safety, and legislations supporting safe patient handling and mobility. In addition, the rising government as well as private initiatives for the rights of the disabled and the elderly to offer improved health care services are also propelling the market for medical lifting slings. <br /><br />According to a study presented by Transparency Market Research, in 2014, the global market for medical lifting slings was worth US$312 mn and is estimated to reach a value of US$632.8 mn by the end of 2023. The market is projected to exhibit a progressive 7.80% CAGR between 2015 and 2023.<br /><br /><b>Universal Lifting Slings Segment Led Global Medical Lifting Slings Market in 2014</b><br /><br />On the other hand, the absence of technical expertise and training provisions in developing economies is expected to hamper the growth of the global medical lifting sling market in the next few years. The global market for medical lifting slings can be divided on the basis of product into:<br />Bariatric Sling<br />Universal Sling<br />Hammock Sling<br />Seating Sling<br />Toileting Sling<br />Stander Sling<br />Transfer Sling<br />Others<br /><br />The others segment is sub-divided into tri-turner slings, bath, pool, and spa lifting slings, and pediatric slings. In 2014, the universal sling segment witnessed the highest growth rate and is expected to remain in the leading position in the coming years. The high growth of this segment can be attributed to its several beneficial features such as the ability to provide back and neck support, high comfort, and several applications including transferring a patient from a bed to chair, or from floor to bed, or chair to chair, and others. Bariatric slings hold the second position in the overall market owing to the growing prevalence of obesity across the globe.<br /><br />The major players operating in the global market for medical lifting slings include GF Health Products, Inc., Joerns Healthcare, LLC, Argo Medical Inc., Etac AB, DJO Global, Invacare Corporation, Prism Medical, Bestcare, LLC, ArjoHuntleigh, and Drive DeVilbiss Healthcare.<br /><br /><b>Download Report Sample: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6559">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6559</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><b><br />Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-40944809330829237362016-03-03T04:08:00.004-08:002016-03-03T04:08:42.377-08:00Global Aged Care Market Classified as Home Care Services And Residential Care Services<div dir="ltr" style="text-align: left;" trbidi="on">
Most of us want to remain independent and stay in control, but due to growing age our ability starts to decline. Hence, the concept of aged care is introduced, for an easy and better living with proper nursing facility for the higher age group. It is also known as elderly care or eldercare. It emphasizes on the personal and social needs of senior citizens as they need some assistance in their daily activities and medical support who desire to age gracefully. A special act has been taken by the Australian Government for senior citizens known as The Aged Care Act 1997 for people who are unable to live independently of their own. It promises to provides them better and longer living. It is an important distinction that the designing of house, services, activities and employee training of global elderly care falls under the unpaid market sector. <br /><br /><b>Browse Full Report With TOC: <a href="http://www.transparencymarketresearch.com/aged-care-market.html">http://www.transparencymarketresearch.com/aged-care-market.html</a></b><br /><br />The main agenda is to ensure that eldercare services are targeted towards people and areas with the utmost need, it facilitate access to aged care services by those who need them, irrespective of culture, race, language, gender and economic background. Focus is also given on people who are homeless or lives in remote areas and special care is also provided for lesbian, gay, bisexual, transgender and intersex (LGBTI) group. Programs are being adopted for the community based care for older people those are Commonwealth Home Support Program (CHSP) and Home Care Packages Program. These provides coordinated and personalized home care and also offers four classes of package to assist aged people with simple, low, high and very high care needs.<br /><br />Aged care market has lot to offer for the special service providers who are capable to run long-term as well as short-term aged care home, nutraceutical manufacturers, pharmaceutical manufacturers, senior care furniture manufacturers and real estate companies. Special products are being marketed for aged people such as smart seat hair protector, water proof seat protectors, and bed pads.<br /><br />It has already made an impact in developed countries like USA, Canada, and Australia. The aged care market is gaining its popularity in the developing countries like China, Singapore and India, as the major proportion of population is above 65 years. More elderly people will take up aged care services in the future rather depending on their families for care and support as younger people are moving to different cities leaving behind their extended family.<br /><br />Aged care market can be divided on the basis of services and geography. Services can be classified as home care services and residential care services.<br /><br />In home care services, they provide medical or nonmedical benefits which include personal care, skilled-nursing care, companion facilities, physical therapy and medical social services. It also includes in-home hospice care provider.<br /><br />In residential aged care, they provides well maintained accommodation for those whose care cannot be met in their own homes and thus needs a special care cell. There are again two categories in residential aged care facilities these are respite care and permanent care. Respite care offers short-term and temporary care in a residential aged care facility and supports both the older people and their care givers to live at home for as long as possible. They provide both high and low care facility. On the other hand permanent care offers tailor made individual needs in the residential aged care facility.<br /><br />Some of the key players can be divided on the basis of pharmaceutical manufacturer like Pfizer, Novartis, Merck & Co., GlaxoSmithKline, AstraZeneca and Novo Nordisk. On the basis of nutraceutical manufacturer like Alkemists Labs, Asiamerica Ingredients, Inc., Barrington Nutritionals, Nutralliance, Inc., and Proprietary Nutritionals Inc. Senior care furniture manufacturers can be classified as Phoenix Contract, Inc., Flexsteel and Kwalu.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9512">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9512</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-20496068720539483702016-03-03T02:39:00.002-08:002016-03-03T02:39:14.564-08:00Global Thyroid Gland Disorders Treatment Market Rides on Increasing Cases of Hypothyroidism<div dir="ltr" style="text-align: left;" trbidi="on">
The thyroid gland is a small butterfly-shaped gland found at the base of the neck, producing thyroid hormones. The hormones produced by the thyroid influence vital functions in a human body, such as stimulating growth and other metabolic processes. Both underactive and overactive thyroid may be the root of disorders ranging from harmless goiter or an enlarged gland that may not require advanced treatment procedures, to life-threatening cancer. <br /><b><br />Browse Full Report: <a href="http://www.transparencymarketresearch.com/thyroid-gland-disorder-market.html">http://www.transparencymarketresearch.com/thyroid-gland-disorder-market.html</a></b><br /><br />According to surveys conducted recently, thyroid gland disorders, the most common of them being hyperthyroidism, hypothyroidism, and thyroid nodules, affect about 5% to 10% of the global population. The increasing incidence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis is often associated with the rising prevalence of hyperthyroidism and hypothyroidism. Iodine deficiency, which has been identified as a widespread problem globally, also aids the high incidence of thyroid gland disorders. These aforementioned factors, coupled with the growing geriatric population worldwide, fuel demand from the global thyroid disorder treatment market. <br /><br /><b>North America Dominates Global Thyroid Gland Disorders Treatment Market</b><br /><br />In its latest report, Transparency Market Research pegs the value of the global thyroid gland disorders treatment market at US$1.8 bn in 2014. By 2023, the market is anticipated to reach US$2.4 bn, rising at a moderate yet steady CAGR of 3.10% between 2015 and 2023. Among the key regional markets, North America registered its dominance in the global thyroid gland disorders treatment market. A survey conducted by the National Health and Nutrition Examination Survey in July 2012 revealed that the prevalence of hypothyroidism in the U.S. alone varies from 4.6% to 9.5%. Alongside the high prevalence of thyroid gland disorders in North America, the region also observes favorable reimbursements policies for the medical and healthcare sector, due to which the market for thyroid gland disorders treatment is thriving in the region. <br /><br /><b>Asia Pacific to Exhibit Fastest Growth among Regional Markets for Thyroid Gland Disorders Treatment</b><br />High prevalence of thyroid disorders and growing awareness about suitable treatments for the same are observed in the emerging economies of Asia Pacific. With increasing access to thyroid disorders treatment, Asia Pacific is anticipated to exhibit the fastest growth as a lucrative market for such treatments. Increasing demand for thyroid gland disorders treatment is particularly witnessed from countries such as India, Japan, China, and Malaysia. These countries are substantially contributing to the growth of the thyroid gland disorders treatment market in Asia Pacific. Increasing consumption of generic formulations across the prominent economies of the region aids the rapid expansion of the market in Asia Pacific and also mitigates the issue of low sales revenue. As governments of the leading economies in Asia Pacific increase their investments in the healthcare sector, the thyroid gland disorders market is likely to gain much impetus. <br /><br />The Latin America market for thyroid gland disorders treatment will also exhibit slow yet steady growth between 2015 and 2023. The improving healthcare scenario in the region, together with the rising incidence of thyroid disorders, will fuel the market for thyroid gland disorders treatment in Latin America. <br /><b><br />Request For Sample Report: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-44802980094913588642016-03-02T06:25:00.003-08:002016-03-02T06:25:39.628-08:00Global Testing and Analysis Services Market to Reach US$29.1 bn by 2023 owing to Growing Trend of Outsourcing<div dir="ltr" style="text-align: left;" trbidi="on">
Testing and analysis services are an integral part of various industries as they have the potential to save money and time by performing important analysis throughout the product development cycle. Testing and analysis services help various industries improve customer satisfaction by delivering quality products. Over the past few years, there has been an increase in the number of testing laboratories. The primary objective of testing and analysis service companies is to make sure that all products reach their highest quality before entering the market. <br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/testing-analysis-services-market.html">http://www.transparencymarketresearch.com/testing-analysis-services-market.html</a><br /> </b><br />
<b>New Food Testing Centers to Propel Global Testing and Analysis Services Market</b><br /><br />With new testing and analysis centers being introduced by the leading players as well as new entrants, the global testing and analysis services market is predicted to expand at a rapid pace during the forecast period. Recently, Eurofins inaugurated its new food testing center to be a part of the Food Authenticity Network in the U.K. Eurofins Food Testing U.K. uses stable isotope techniques and DNA analysis to determine the geographical origin and authenticity of food and feed commodities including dairy products, meat, fruit, wine, honey, and vegetables. <br /><br />The Food Authenticity Network deals with food mislabeling and fraud and also gives easy access to users to professional laboratories that provide food testing and analysis services. Eurofins Food Testing U.K. recently joined Campden BRI, the Institute of Food Research, Fera Science, West Yorkshire Analytical Services, Leatherhehttp://www.pressreleaseping.com/global-testing-and-analysis-services-market-reach-us291-bn-2023-owing-growing-trend-outsourcingad Food Research, LGC, and Premier Analytical Services under the proficiency tab of the U.K. Centers of Expertise in food authenticity testing. <br /><br />The increasing number of testing and analysis service centers across the globe is expected to contribute to the growth of the global testing and analysis services market in the next few years. The global testing and analysis services market was valued at US$17.9 bn in 2014 and is expected to reach US$29.1 bn by 2023, progressing at a 5.60% CAGR during the period between 2015 and 2023. <br /><br /><b>North America to Register Maximum Demand for Testing and Analysis Services </b><br /><br />The global testing and analysis services market is segmented on the basis of sample type, analysis type, industry, and geography. Food and beverages, pharma and medical devices, minerals, chemicals, environment and agriculture, metal and alloys, and oil and gas are some of the industries where testing and analysis services are effectively used. In 2014, in terms of revenue, the food and beverage segment dominated the global testing and analysis services market.<br /><br />Based on geography, the global testing and analysis services market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East and Africa, and Rest of the World. In 2014, in terms of value, North America led the global testing and analysis services market, followed by Europe. Bureau Veritas, Intertek Group plc, Eurofins, TÜV Rheinland, Maxxam, TÜV SÜD, LECO Corporation, SGS S.A., ALS Global, Exova, Acuren, Koninklijke Philips N.V., and Applus are some of the leading companies in the global testing and analysis services market. The global testing and analysis services market is expected to be highly competitive in the years to come due to the introduction of new testing and analysis services by the new entrants. <br /><br />By analysis type, the global testing and analysis services market is classified into elemental, organic, isotopic, particle size, mineralogical, metallurgical, petroleum, biomedical, and others. In 2014, the elemental testing and analysis services segment dominated the global testing and analysis services market. Around 44% of SMEs/businesses outsource elemental testing and analysis services to analytical testing companies.<br /><br />Based on sample type, the global testing and analysis services market is classified into water, soil or sediment, clay mineral, metal alloy, biological sample, food, chemicals, corrosion, oil and gas, mineral, and service.<br /><br /><b>Download Free Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7643">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7643</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-14305761544071905822016-03-02T06:03:00.005-08:002016-03-02T06:03:44.607-08:00Parenteral Nutrition Market Is Projected Growth at Highest CAGR due to Rising Demand for this Nutrient <div dir="ltr" style="text-align: left;" trbidi="on">
Parenteral nutrition refers to the intravenous administration of specialized nutrition solutions such as carbohydrates, single dose amino acids, parenteral lipid emulsions, vitamins and trace elements. This administration method requires when patient’s gastrointestinal track is not working or patients is not adequately nourished by oral or enteral route. This report studies the global parenteral nutrition market in a view of different types of nutrient i.e. carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements. The report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.<br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/parenteral-nutrition-market.html">http://www.transparencymarketresearch.com/parenteral-nutrition-market.html</a></b><br /><br />A detailed qualitative analysis of the About factors responsible for driving and restraining the growth of the global parenteral nutrition market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Force analysis, event impact analysis and market attractiveness analysis. Additionally, market share analysis in a view of different geographies (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) and different parenteral nutrients (carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements) have also been covered under the scope of the report.<br /><br />Based on type of nutrient, the global parenteral nutrition market has been has been extensively analyzed into carbohydrates, single dose amino acid solutions, parenteral lipid emulsion, trace elements, vitamins and minerals. The market size and forecast in terms of USD million for each type of nutrient has been provided for the period from 2013 to 2023. The report on the parenteral nutrition market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.<br /><br />Geographically, the parenteral nutrition market been categorized into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA) which are further divided based on the respective countries. The market size and forecast for each of these regions and countries have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.<br /><br />A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the parenteral nutrition market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc (Actavis plc), Baxter International, Inc., B. Braun Melsungen AG, Claris Lifesciences Limited, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc. (Hospira, Inc.) and others.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email:<a href="http://sales@transparencymarketresearch.com/"> sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-43761692116733875032016-03-02T05:00:00.005-08:002016-03-02T05:00:54.487-08:00Could Cord Blood Banking be the Lifeline for Future Generations?<div dir="ltr" style="text-align: left;" trbidi="on">
Several couples in recent years have realized the potential of umbilical cord blood, making cord blood banking a priority. By choosing to bank cord blood, parents not only open up the possibility of saving their child’s life if it is threatened by a disease, but also the life of a family member, relative, or a stranger. Cord blood refers to blood extracted from the umbilical cord and the placenta after the baby is born. The reason cord blood is stored in medical facilities across the world is that the blood cells it contains have the ability to renew themselves.<br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html">http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html</a></b><br /><b><br />Rising Awareness about Cord Blood Banking Gives an Impetus to Blood Banking Services</b><br /><br />As more and more parents are realizing the importance of saving cord blood, banking units that offer services such as collection and preservation are booming, especially in Latin American countries. The top players in the Latin America cord blood baking services market are Banco de Cordon Umbilical (BCU), Redcord S.A., America Cell Biobank, Inc., and CrioCenter. These banks are either private cord blood banking services or public cord blood banking services. Most of them are operating in countries such as Brazil, Colombia, Argentina, and Mexico. <br /><br /><b>Growing Stem Cell Research Promotes Cord Blood Banking</b><br /><br />Umbilical cord blood has a huge potential to be the source of progenitor cells that are usually used for the reconstitution of organs, tissues, and other functional areas. Today, cord blood transplantation is being used for treating a variety of diseases such a sarcoma, leukemia, lymphoma, and several other immune conditions and metabolic disorders. In the last twenty years, the stem cell therapeutics industry has also experienced a surge due to increasing investment and growing research and development. <br /><br /><b>Private Cord Blood Banking Services Toughen the Competition in the Market</b><br /><br />The rise in technological and infrastructural development in Latin American countries has encouraged research into stem cell therapy, which has given cord blood banking a positive momentum. Most cord blood banking services in Latin America are being funded by governments. However, as private players are slowly making their way into the Latin American market, they are likely to make the scenario highly competitive for the existing players.<br /><br />In the coming years, countries in Latin America are expected to make a serious effort at reducing the limitation of public and private cord blood banking by executing a hybrid model. This model will entail the storage of cord blood for a dual purpose. One part of it will be used for the child or for the donor family, while the second portion will be used as a public donation. With the myriad possibilities that cord blood banking services offer and the remarkable progress in stem cell research, saving this blood could prove to be lifeline for future generations.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-8238755558928068982016-03-02T03:41:00.006-08:002016-03-02T03:41:48.630-08:00Veterinary Antiseptics Market to Reach US$401.6 mn by 2023, Propelled by Increasing Applications of Antiseptics<div dir="ltr" style="text-align: left;" trbidi="on">
Zoetis, Inc., a global animal health company based in New Jersey, recently completed the construction of a 19,000-square-foot, three-story addition to its production site in the Lincoln province of Nebraska. Zoetis introduced its new product, Canine Atopic Dermatitis Immunotherapeutic, which is an antibody therapy for dogs, targeted at reducing atopic dermatitis. The company also introduced a vaccine that cures PEDv, one of the emerging diseases that recently destroyed pig farms in the U.S. The new plant will facilitate the manufacturing of an injectable hormone, Synovex, which promotes weight gain in cattle. According to the authorities at Zoetis, Inc., the product will be ready to be supplied to customers by 2016. <br /><b><br />Browse Research Report: <a href="http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html">http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html</a></b><br /><br />Last year, Zoetis was engaged in manufacturing a vaccine to cure porcine epidemic diarrhea virus. The company will expand its animal healthcare services in Lincoln and offer reliable animal health products to livestock suppliers, veterinarians, and pet owners. Zoetis, Inc. will be looking to spread its services with new products that are meant to fulfill the changing market needs and assist veterinarians in improving their approach to animal treatment and disease prevention. <br /><br />According to Transparency Market Research, the veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World stood at US$243.0 mn in 2014 and is expected to reach US$401.6 mn by 2023, at a 5.60% CAGR. <br /><br /><b>Iodine and Iodophors Sector to Register Highest Growth</b><br /><br />Safer and more effective varieties of antiseptics, used for cleaning the skin and wounds, are being adopted by veterinarians and animal care clinics to treat pets. The veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World is segmented on the basis of product type into iodine and iodophors, alcohol, chlorhexidine, hydrogen peroxide, and others. In veterinary care, iodine and iodophors are the most commonly used antiseptics. The iodine and iodophors sector accounted for the highest market share in 2014 and is expected to maintain its dominant position by 2023. Iodophors also act as a suitable carrier for iodine and provide prolonged and sustained release of antiseptics. Iodophors and iodine are effective against fungi, bacteria, and viruses. <br /><br />Chlorhexidine is commonly used as an antiseptic for common domestic animals such as horse, dogs, cats, cows, sheep, and poultry animals. Alcohol is used before vaccination in small animals including dogs, sheep, and cats. Based on species, veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World is classified into bovine, porcine, ovine, equine, canine, feline, and camelidae. In terms of consumption trends and population analysis, the bovine antiseptics sector accounted for the highest market share in 2014.<br /><br /><br /><b>Introduction of Advanced Antiseptics to Boost Veterinary Antiseptics Market</b><br /><br />Strict regulatory guidelines are expected to restrict the growth of the veterinary antiseptics market. However, the introduction of new veterinary antiseptics by the leading market players is predicted to boost the growth prospects of the market during the forecast period. Some of the leading companies in the veterinary antiseptics market in Latin America, Asia Pacific, and Rest of the World are Bayer AG, Elanco Animal Health, Inc., M.B.D. Marketing (S) Pte Ltd., Merial, Vallée S.A, Zoetis, Inc., Continental Manufacturing Chemist, Inc., Indian Immunologicals Ltd., Merck Animal Health, and Nicosia International.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6448">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6448</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><b><br />Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-87328709231381907252016-03-01T05:12:00.002-08:002016-03-01T05:12:12.040-08:00Global Gamma and Scintillation Cameras and Accessories Market to Witness Substantial Growth in APAC<div dir="ltr" style="text-align: left;" trbidi="on">
A featured report from Transparency Market Research (TMR) offers the latest insights into the global gamma and scintillation cameras and accessories market. This report is titled “Gamma and Scintillation Cameras and Accessories Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”<br /><b><br />Browse Full Report: <a href="http://www.transparencymarketresearch.com/gamma-scintillation-cameras-accessories.html">http://www.transparencymarketresearch.com/gamma-scintillation-cameras-accessories.html</a></b><br /><br />According to the report, the global gamma and scintillation cameras and accessories market will be driven by the continued advancement in molecular imaging and the rising demand for new drug development. In addition to this, the global gamma and scintillation cameras and accessories market will also benefit from the increasing incidence of several chronic conditions such as cardiovascular diseases, cancer, and neurological disorders. These conditions call for accurate diagnosis, driving the overall gamma and scintillation cameras and accessories market.<br /><br />This trend is pushing companies in the global gamma and scintillation cameras and accessories market to develop diagnostic products equipped with innovative features. On the other hand, the growing popularity of PET procedures is challenging the global gamma and scintillation cameras and accessories market.<br /><br />A scintillation or gamma camera is used to image body organs by identifying the gamma rays emitted due to the administering of radioactive isotopes. This method is known as scintigraphy. At present, these cameras are employed to image tissues and organs in an optimized time with more accurate results as compared to traditional scanners. Gamma/scintillation cameras and accessories are used around the world for these diagnostic purposes. Regionally, the global gamma and scintillation cameras and accessories market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW).<br /><br />Currently, Europe and North America are leading the global gamma and scintillation cameras and accessories market. These markets are driven by the well-established healthcare infrastructure and rising awareness among consumers regarding the technology in these regions. The key emerging markets anticipated to witness substantial growth in the coming few years in the global gamma and scintillation cameras and accessories market are Mexico, Brazil, India, and China. These emerging markets benefit from their developing economy, leading to enhanced access to healthcare. Moreover, these markets also benefit from the growing involvement of health insurance companies in these countries.<br /><br />The rapidly developing market in Asia Pacific will offer significant growth opportunities to players operating in the global gamma and scintillation cameras and accessories market. The most prominent companies covered in the report are Mediso Medical Imaging Systems, GE Healthcare, Philips Healthcare, Siemens Healthcare, Acrorad Co., Ltd., Gamma Medica-Ideas, and Digirad Corporation. By product, gamma cameras hold a significant share in the global gamma and scintillation cameras and accessories market.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1652">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1652</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. <br /><br />TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.<br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br />USA - Canada Toll Free: 866-552-3453<br /><b>Email: <a href="http://sales@transparencymarketresearch.com/">sales@transparencymarketresearch.com </a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-13346757155840155972016-03-01T03:37:00.001-08:002016-03-01T03:37:19.309-08:00Global Cocaine Dependence Treatment Market to be Driven by Introduction of Vaccines for Treatment<div dir="ltr" style="text-align: left;" trbidi="on">
A new market research report by Transparency Market Research provides a detailed analysis of the global market for cocaine dependence treatment. The study emphasizes on the market overview, product segmentation, market drivers and restraints, current market trends, challenges and opportunities, major geographical segments, and competitive landscape of the market. The research report, titled “Cocaine Dependence Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” further includes the forecast figures and historical data of the market along with strategic recommendations and valued inputs so as to guide existing as well as new players in designing their business policies.<br /><br /><b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html">http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html</a></b><br />The growing youth population has been abusing cocaine in increasing numbers and the health effects of abusing it are quite severe. As a result, the demand for cocaine de-addiction has been gaining traction in recent years. In addition, the growing awareness regarding the ill-effects of cocaine abuse is further expected to fuel the growth of the global market for cocaine dependence treatment in the coming years. The introduction of vaccines for cocaine dependence treatment is considered as a potential opportunity for the major players in this market. However, the rigid regulatory approval process is hampering the growth of the market. <br /><br />On the basis of medication type, the global market for cocaine dependence treatment has been segmented into Vigabatrin, Gabapentin, N-acetylcysteine (NAC), Nocaine, Propanolol, Disulfiram, Baclofen, and Modafinil, whereas on the basis of treatment type, the global market for cocaine dependence treatment has been classified into intensive outpatient rehab, inpatient cocaine rehab, withdrawal treatment and detox centers, and addiction counseling and aftercare. The market share and estimates of each segment have been included in the research study.<br /><br />The research study has further classified the global market for cocaine dependence treatment on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Currently, North America accounts for the largest share in the overall market owing to the high number of cocaine users in this region. Even though more cocaine addiction cases are being reported in several developing economies, the bulk of cocaine is still being consumed in several parts of Europe and North America. The developing economies in South America, the Caribbean, and Central America are the potential markets for cocaine dependence treatments. As per the study, collectively these regions have approximately 3 million cocaine users.<br /><br />Furthermore, the research study talks about the competitive landscape of the global market for cocaine dependence treatment, including the company overview, inception details, contact information, product portfolio, financial overview, business policies, SWOT analysis, and recent developments such as major mergers and acquisitions. The major players operating in the global market for cocaine dependence treatment include Pfizer Inc., Savant HWP, Inc., Lannett Company, Inc., and Catalyst Pharmaceutical Partners, Inc.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2518">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2518</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. <br /><br />TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.<br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br />USA - Canada Toll Free: 866-552-3453<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-58885847007080070062016-03-01T03:25:00.004-08:002016-03-01T03:25:39.751-08:00Global Cocaine Dependence Treatment Market to be Driven by Introduction of Vaccines for Treatment<div dir="ltr" style="text-align: left;" trbidi="on">
A new market research report by Transparency Market Research provides a detailed analysis of the global market for cocaine dependence treatment. The study emphasizes on the market overview, product segmentation, market drivers and restraints, current market trends, challenges and opportunities, major geographical segments, and competitive landscape of the market. The research report, titled “Cocaine Dependence Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” further includes the forecast figures and historical data of the market along with strategic recommendations and valued inputs so as to guide existing as well as new players in designing their business policies.<br /><br /><b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html">http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html</a></b><br /><br />The growing youth population has been abusing cocaine in increasing numbers and the health effects of abusing it are quite severe. As a result, the demand for cocaine de-addiction has been gaining traction in recent years. In addition, the growing awareness regarding the ill-effects of cocaine abuse is further expected to fuel the growth of the global market for cocaine dependence treatment in the coming years. The introduction of vaccines for cocaine dependence treatment is considered as a potential opportunity for the major players in this market. However, the rigid regulatory approval process is hampering the growth of the market. <br /><br />On the basis of medication type, the global market for cocaine dependence treatment has been segmented into Vigabatrin, Gabapentin, N-acetylcysteine (NAC), Nocaine, Propanolol, Disulfiram, Baclofen, and Modafinil, whereas on the basis of treatment type, the global market for cocaine dependence treatment has been classified into intensive outpatient rehab, inpatient cocaine rehab, withdrawal treatment and detox centers, and addiction counseling and aftercare. The market share and estimates of each segment have been included in the research study.<br /><br />The research study has further classified the global market for cocaine dependence treatment on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Currently, North America accounts for the largest share in the overall market owing to the high number of cocaine users in this region. Even though more cocaine addiction cases are being reported in several developing economies, the bulk of cocaine is still being consumed in several parts of Europe and North America. The developing economies in South America, the Caribbean, and Central America are the potential markets for cocaine dependence treatments. As per the study, collectively these regions have approximately 3 million cocaine users.<br /><br />Furthermore, the research study talks about the competitive landscape of the global market for cocaine dependence treatment, including the company overview, inception details, contact information, product portfolio, financial overview, business policies, SWOT analysis, and recent developments such as major mergers and acquisitions. The major players operating in the global market for cocaine dependence treatment include Pfizer Inc., Savant HWP, Inc., Lannett Company, Inc., and Catalyst Pharmaceutical Partners, Inc.<br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2518">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2518</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. <br /><br />TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.<br /><b><br />Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br />USA - Canada Toll Free: 866-552-3453<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-60243185407189078852016-03-01T02:32:00.001-08:002016-03-01T02:32:23.523-08:00North America Leads Global Hormone Replacement Therapy Market due to Developed Economy<div dir="ltr" style="text-align: left;" trbidi="on">
Transparency Market Research, a reputed research company, offers a thoroughly researched report about the global hormone replacement therapy market. The research report, titled “Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 – 2018,” details the important elements influencing the trajectory of the market. Furthermore, it also uses market measurement tools such as SWOT analysis and Porter’s five forces analysis to determine the strengths, weaknesses, opportunities, and threats and the threats from new entrants, the threat of substitute products or services, the bargaining power of customers, the bargaining power of suppliers, and the intensity of competitive rivalry in the market. Additionally, expert industry analysts have also studied this market from a political, economic, social, technological, legal, and environmental point of view to provide a holistic outlook of the global hormone replacement therapy market.<br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/hormone-replacement-therapy-market.html">http://www.transparencymarketresearch.com/hormone-replacement-therapy-market.html</a></b><br /><br />Hormone replacement therapy (HRT) refers to helping patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed. These hormones are administered through implants, oral tables, vaginal creams, and patches, amongst others.<br /><br />According to the research report, the global hormone replacement therapy market is segmented into estrogen replacement therapy, thyroid hormone replacement therapy, and growth hormone replacement therapy. Currently, the estrogen replacement therapy segment holds the largest share in the global hormone replacement therapy market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people.<br /><br />The key growth driver of the global hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are the emergence of innovative drug delivery methods and the unmet needs in Asian markets. Geographically, North America holds the largest share in the global hormone replacement therapy market due to its developed economy and increasing purchasing power of patients.<br /><br />Some of the key players profiled in the global hormone Noven Pharmaceuticals, Amgen, Pfizer, BioSante Pharmaceuticals, and Merck & co., QuatRx Pharmaceuticals, and Depomed Inc., amongst others. The research report details the competitive landscape of the global hormone replace therapy market by analyzing the key market drivers and restraints and the impact of the regulatory framework. The research report also offers an insightful take on the financial overview, research and development activities, business and marketing strategies, product portfolio, and strategic mergers and acquisitions of these top players. <br /><br /><b>Download Report Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=610">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=610</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. <br /><br />TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.<br /><br /><b>Contact Us:-</b><br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br />USA - Canada Toll Free: 866-552-3453<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-42660660360512334252016-02-19T05:12:00.001-08:002016-02-19T05:12:24.821-08:00Primary Immunodeficiency Diseases Market worth US$7.5 bn by 2023, Newborn Screening in Emerging Markets to be Key Opportunity<div dir="ltr" style="text-align: left;" trbidi="on">
Primary immunodeficiency disease (PIDD) comprises group of rare disorders, mostly genetic in nature, wherein a part of the immune system is missing or does not function correctly. The symptoms include a markedly increased vulnerability to serious illness and infection, organ damage and the immune system also attacking the body’s own tissues and cells. Primary Immunodeficiency is largely treated with therapies derived from human plasma, and in the most severe forms, replacement of stem cells. The report on global primary immunodeficiency diseases market by treatment has been studied and assessed for four prominent categories: Immunoglobulin Replacement Therapy, Antibiotic Therapy, Stem cells and gene therapy and others. The market for others provide a cumulative estimation for vaccines and nutritional supplement.<br /><br /><b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html">http://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html</a></b><br /><br />Immunoglobulin (Ig) has been used to treat hypogammaglobulinaemia for more than two decades or more. Recently, it has also been used to treat diseases such as combined immunodeficiency and partial antibody deficiency. Ig are as a replacement therapy are usually administered via two prominent modes i.e. intravenous and subcutaneous which has well demonstrated their efficacy and safety in primary immunodeficiency (PIDD) treatment. A recent survey published by the Medical Insights Groups in 2014 illustrated that 54% of home-based Ig are delivered through SC, whereas only 46% are considered for IV in the U.S. Demand for SC is growing rapidly especially among school going children as it can be delivered in home settings with a one hour infusion, whereas venous access requires three to four hour infusion for IVIG.<br /><br />Long-term prophylactic antibiotics are being widely implemented as primary or adjunctive therapy for PIDD treatment. This practice has transformed clinical outcomes in the setting of chronic granulomatous disease, complement deficiencies, Wiskott-Aldrich syndrome, hyper IgE syndrome. Patients with PIDD are often prescribed longer and stronger courses of antibiotics than usual. This could mean courses of 14 days or sometimes longer. The reason for this is to prevent relapse or recurrence of infection. Some of the commonly used antibiotics in PIDD treatment include penicillin, cephalosporins, macrolides, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides.<br /><br />Hematopoietic stem cell treatment (HSCT) successfully cures a wide range of primary immunodeficiency disorders. Advances in medical science has led to an improved survival rate and better quality of life, especially with respect to orphan diseases. HSCT owing to its better outcomes is now increasingly practiced for treating non-SCID based patients suffering from diseases such as Wiskott-Aldrich syndrome, Omenn syndrome, CD40 ligand deficiency and others. Gene therapy has been used to treat patients with SCID due to adenosine deaminase (ADA) deficiency, X-linked severe combined immunodeficiency, chronic granulomatous disease, and Wiskott-Aldrich syndrome. Various laboratories across the world are working at modifications of the viral vectors in order to improve their safety. Stem cells and gene therapy market is expected to be the fastest growing segment during the forecast tenure owing to increasing number of clinical trial and research studies and significant reduction in mortality and morbidity in past few years. <br /><br />Lack of adequate nutrition can also lead to many illnesses including infections for which the individual with primary immunodeficiency disease is already at risk. Vitamin supplements include vitamins A, C, and E, which are all valuable parts of the body's defense system aid in increasing the production of healthy white blood cells and to fight infection.<br /><br />The report offers a detailed description behind this high growth and outlines a possible growth trajectory for other segments of PIDD market such as by diseases, by test and by geography. The market study also profiled some of the leading companies operating in primary immunodeficiency diseases market across the globe. These encompasses Baxter International, Inc., Biotest AG, CSL Behring LLC, Bio Products Laboratory Ltd., Kedrion S.p.A., LFB S.A., Octapharma AG and Grifols S.A.<br /><br />The global primary immunodeficiency diseases market is segmented into the following categories:<br />Global Primary Immunodeficiency Diseases Market, by Disease<br /><br />Antibody Deficiency<br />Agammaglobulinaemia ((X-Linked and Autosomal Recessive)<br />Common Variable Immune Deficiency<br />Selective IgA Deficiency<br />IgG Subclass Deficiency<br />Others<br /><br />Cellular Immunodeficiency<br />Ataxia Telangiectasia<br />Hyper IgM Syndromes<br />Wiskott-Aldrich Syndrome<br />DiGeorge Syndrome<br />Others<br /><br />Innate Immune Disorders<br />Complement Deficiencies<br />Hyper IgE Syndrome<br />Others<br /><br />Global Primary Immunodeficiency Diseases Market, by Test<br />Blood Test<br />Prenatal Testing<br /><br />Global Primary Immunodeficiency Diseases Market, by Treatment<br />Immunoglobulin Replacement Therapy<br />Antibiotic Therapy<br />Stem cell and Gene Therapy<br />Others<br /><br /><b>Request For Sample Report: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><b><br />Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-11066875808491854342016-02-19T02:46:00.004-08:002016-02-19T02:46:48.427-08:00Could Cord Blood Banking be the Lifeline for Future Generations?<div dir="ltr" style="text-align: left;" trbidi="on">
Several couples in recent years have realized the potential of umbilical cord blood, making cord blood banking a priority. By choosing to bank cord blood, parents not only open up the possibility of saving their child’s life if it is threatened by a disease, but also the life of a family member, relative, or a stranger. Cord blood refers to blood extracted from the umbilical cord and the placenta after the baby is born. The reason cord blood is stored in medical facilities across the world is that the blood cells it contains have the ability to renew themselves.<br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html">http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html</a></b><br /><br /><b>Rising Awareness about Cord Blood Banking Gives an Impetus to Blood Banking Services</b><br /><br />As more and more parents are realizing the importance of saving cord blood, banking units that offer services such as collection and preservation are booming, especially in Latin American countries. The top players in the Latin America cord blood baking services market are Banco de Cordon Umbilical (BCU), Redcord S.A., America Cell Biobank, Inc., and CrioCenter. These banks are either private cord blood banking services or public cord blood banking services. Most of them are operating in countries such as Brazil, Colombia, Argentina, and Mexico. <br /><br /><b>Growing Stem Cell Research Promotes Cord Blood Banking</b><br /><br />Umbilical cord blood has a huge potential to be the source of progenitor cells that are usually used for the reconstitution of organs, tissues, and other functional areas. Today, cord blood transplantation is being used for treating a variety of diseases such a sarcoma, leukemia, lymphoma, and several other immune conditions and metabolic disorders. In the last twenty years, the stem cell therapeutics industry has also experienced a surge due to increasing investment and growing research and development. <br /><br /><b>Private Cord Blood Banking Services Toughen the Competition in the Market</b><br /><br />The rise in technological and infrastructural development in Latin American countries has encouraged research into stem cell therapy, which has given cord blood banking a positive momentum. Most cord blood banking services in Latin America are being funded by governments. However, as private players are slowly making their way into the Latin American market, they are likely to make the scenario highly competitive for the existing players.<br /><br /><b>Browse Press Release: <a href="http://www.transparencymarketresearch.com/pressrelease/latam-cord-blood-banking-services-market.htm">http://www.transparencymarketresearch.com/pressrelease/latam-cord-blood-banking-services-market.htm</a></b><br /><br />In the coming years, countries in Latin America are expected to make a serious effort at reducing the limitation of public and private cord blood banking by executing a hybrid model. This model will entail the storage of cord blood for a dual purpose. One part of it will be used for the child or for the donor family, while the second portion will be used as a public donation. With the myriad possibilities that cord blood banking services offer and the remarkable progress in stem cell research, saving this blood could prove to be lifeline for future generations.<br /><b><br />Download PDF Brochure: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-58748547198083088752016-01-12T02:53:00.000-08:002016-01-12T02:53:05.352-08:00global allergy diagnostics market is poised to grow at the highest rate<div dir="ltr" style="text-align: left;" trbidi="on">
Allergic reactions occur due to a hypersensitivity disorder of the immune system against certain substances present in the environment, which are often referred as allergens such as dust mites excretion, pollen, and pet dander. Allergic reactions have a detrimental impact on the human health causing significant morbidity due to otolaryngologic, pulmonary, and dermatologic disorders. According to an article published by the National Center for Biotechnology Information (NCBI), over 500 million people are suffering from allergic rhinitis globally. <br /><br /><b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/allergy-diagnostics-market.html">http://www.transparencymarketresearch.com/allergy-diagnostics-market.html</a></b><br /><br />The morbidity pattern varies from chronic illnesses such as allergic rhinitis and allergic asthma to acute anaphylaxis from venom or medication. Allergies are observed to affect all age groups, races and ethnicity and economic classes, although, young children and elderly are at higher risk. Factors such as alarming rise in pollution and environmental toxicity, overcrowding due to population rise, lifestyle factors are leading to weakened immune systems and heightened vulnerability towards allergic reactions.<br /><br />According to the World Allergy Organization, nearly 30% to 40% of the global population is affected by one or the other allergic conditions and currently no cure is available for these disorders. Consequently, there is a burgeoning global market for diagnostic services to detect allergies caused by different allergens. The positive test alone demonstrates sensitization but do not always indicate clinical reactivity. The complexity of the allergy diagnosis lies in the fact that the diagnosis does not rest entirely on test results but also needs to incorporate patient’s medical history and the genetic predisposition towards certain allergies. Accurate diagnosis and immunotherapy is the only ray of hope for seeking cure against most of the allergen sensitivities.<br /><br />Some of the allergy diagnostic products and services include allergy markers, ImmunoCAP, recombinant gene technology, and EliA blood tests among others. Allergy diagnostics market is bound to grow in future owing to the current health scenario with parallel rise in demand for accurate diagnostic tools and services. To enable diagnosis and disease management of allergies and autoimmune disorders, allergens have been classified on the basis of product type and end-users: <br /><br />The end-users segment includes healthcare institutions such as medical research centers, laboratories, hospitals, and health insurance companies. Product types can be further subdivided into:<br />Assay Kits and immunoassay analyzers<br />Instruments<br />Consumables<br />Luminometers<br /><br />Immunoassay analyzers are expected to capture a huge share among the global allergy diagnostics market and is poised to grow at the highest rate. To map out the diagnostic allergy market on a global scale, North America accounts for the largest regional market followed by Europe and opening up newer avenues for the rapidly growing markets in Asia-Pacific. This trend is further backed by the statistical information from the European Academy of Allergy and Clinical Immunology (EAACI) which reported in 2012 that nearly 17 million Europeans have food allergies and there has been seven-fold rise in allergic reactions among children over the past decade. One in every thirteen children (under 18 years of age) in the U.S is exposed to this potentially serious condition. Consequently, the market has witnessed a remarkably high growth owing to the increasing awareness coupled with government initiatives for the unmet needs of the population in many countries. It is anticipated that the sector will experience a tremendous growth as a result of the demand side factors, investments in the products and services for detecting the allergic trigger.<br /><br />Some of the key players contributing to this market segment are Allercheck Laboratories, Inc., bioMérieux SA, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., HOB Biotech Group Co., Ltd., HYCOR BioMedical, Lincoln Diagnostics, Inc., Omega Diagnostics Group plc, Siemens Healthcare, Stallergenes, and Thermo Fisher Scientific, Inc.<br /><b><br />Request For Sample Report: <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5147">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5147</a><br /><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><b><br />Contact Us:-</b><br />Mr.Sudip.S<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-56287401473265717052016-01-12T00:18:00.002-08:002016-01-12T00:18:38.053-08:00Spinal Muscular Atrophy (SMA) Market: Phase 3 Candidate ISIS-SMNRx to Reach US$0.47 bn by 2023<div dir="ltr" style="text-align: left;" trbidi="on">
Spinal muscular atrophy is primarily a hereditary autosomal recessive disease that affects the nervous system areas that controls voluntary muscular movement. SMA is commonly identified as a genetic disorder causing mortality among people, especially infants. As per Orphanet, 1 infant out of 6,000 births is predicted to suffer spinal muscular atrophy. More than 10 mn individuals in the United States are carriers of spinal muscular atrophy. The spinal muscular atrophy market phase 3 candidate ISIS-SMNRx is predicted to reach US$0.47 bn by 2023.<br /><br /><b>Increasing Number of Infants with SMA to Drive Global Market</b><br /><br />Recently, as per a news report, a few families in Morgantown found hope for their children who were suffering from spinal muscular atrophy. The families were denied access to the clinical trial drug SMNRx from ISIS Pharmaceuticals. Since then, the families, with the support of many others, have been trying to sign a petition to allow SMA-diagnosed children to have clear access to the relevant drugs for treatment. <br /><br />Such and other events have occurred as the result of the growing prevalence of SMA among children. This will propel the global spinal muscular atrophy market in the coming years.<br /><br /><b>Browse Full Report: <a href="http://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html">http://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html</a></b><br /><br /><b>Type 1 Spinal Muscular Atrophy to Lead Demand for Global SMA Market by 2023</b><br /><br />Considering the increasing number of infants being diagnosed with spinal muscular atrophy, the spinal muscular atrophy market is expected to expand during the period from 2015 to 2023. On the basis of the symptoms and the age of onset, the SMA market is classified into Type 1 SMA, Type 2 SMA, Type 3 SMA, and Type 4 SMA. Type 1 spinal muscular atrophy is the most severe type and is found in infants aged up to six months. More than 60% of SMA cases are found to be Type 1 SMA, in which infants do not live for more than two years. Type 2 SMA affects children aged from six months to 18 months. Type 3 and 4 SMA are comparatively less severe and carry a prognosis of a normal lifespan. Physiotherapy is the best treatment suggested for SMA when it is at its early stage. <br /><br />ISIS-SMNRx is an antisense medicine introduced by Isis Pharmaceutical and has shown positive results in clinical trials. Some other potential candidates are Olesoxime (TRO19622), RO6885247, scAAV9.CB.SMN, RG3039, LMI070, and CK-2127107. Phase 3 study of ISIS-SMNRx for treating Type 1 and Type 2 SMA is expected to be completed by 2016. <br /><br />SMA is commonly diagnosed by recognizing mutation in the survival of motor neuron (SMN) gene. Muscle biopsy, nerve condition velocity, and electromyogram are some other ways by which SMA can be diagnosed. AveXis, Inc., F. Hoffmann-La Roche Ltd., Isis Pharmaceuticals, Inc., Cytokinetics, Inc., and Novartis AG are some of the prominent players in the spinal muscular atrophy market. <br /><b><br />Browse Press Release: <a href="http://www.transparencymarketresearch.com/pressrelease/spinal-muscular-atrophy-market.htm">http://www.transparencymarketresearch.com/pressrelease/spinal-muscular-atrophy-market.htm</a></b><a href="http://www.transparencymarketresearch.com/pressrelease/spinal-muscular-atrophy-market.htm"><br /></a><br />At present, there is no well-defined cure for treating spinal muscular atrophy. ISIS-SMNRx is the only drug that is expected to be made available on large scale by 2017. The drug is expected to reach record sales of US$468.2 mn in the U.S. by 2023. </div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-66648745059017336792015-10-19T02:31:00.000-07:002015-10-19T02:31:25.049-07:00Spinal Muscular Atrophy Phase 3 Candidate ISIS-SMNRx Expected to Reach USD 0.47 Billion in Sales in the U.S<div dir="ltr" style="text-align: left;" trbidi="on">
Spinal muscular atrophy (SMA) is a hereditary autosomal recessive
disease affecting areas of the nervous system that control voluntary
muscle movement. SMA is identified as a leading genetic disorder causing
mortality among infants. According to Orphanet, one infant in 6,000
births is estimated to suffer from SMA. Furthermore, over 10 million
people in the U.S. are carriers of SMA gene. Depending on the age of
onset and symptoms, spinal muscular atrophy is classified in four main
types. Type 1 SMA is the most severe form, and affects infants aged
between zero and six months. Over 60% of annual SMA cases are of type 1
SMA, wherein infants usually do not survive for more than 2 years. Type 2
SMA is a moderate form affecting children aged between six months and
eighteen months. Patients with Type 3 SMA and Type 4 SMA usually have a
normal lifespan. <br />
<img alt="spinal-muscular-atrophy-market" src="http://transparencymarketresearch.com/images/spinal-muscular-atrophy-market.png" /><br />
Currently, no cure exists for spinal muscular atrophy, and treatment is directed towards managing common symptoms of SMA. Physiotherapy is strongly recommended in early stages of the disease to extend range of motion and improve muscle flexibility. Other treatment methods are targeted to treat gastrointestinal and respiratory disorders, which are common in SMA patients. The SMA pipeline is dry, with single drug in phase 3, three in phase 2, and one in phase 3 clinical trials. ISIS-SMNRx by Isis Pharmaceutical is an antisense drug that has shown promising results in phase 2 clinical trials. Phase 3 study of ISIS-SMNRx for treatment of Type 1 SMA and Type 2 SMA is expected to complete in 2016. In the United States, the drug is expected to reach annual sales of USD 0.47 billion by 2023. Olesoxime (TRO19622) has completed its phase2/3 trials, and has shown promising results, with potential to effectively treat type 2 and type 3 SMA. Other potential candidates include Olesoxime (TRO19622), LMI070, RO6885247, CK-2127107, scAAV9.CB.SMN and RG3039.<br /><br />The United States and Europe have higher percentage of diagnosed cases of SMA. Government and private organization in these regions are also involved in creating awareness about the disease. Higher confirmed carrier population would also help in faster market growth in these regions. Furthermore, government incentives for development of therapeutic alternatives for rare diseases also boosts research and development in the SMA landscape.Companies with potential candidates in the spinal muscular atrophy pipeline include AveXis, Inc., Cytokinetics, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, and Isis Pharmaceuticals, Inc. <br /><br /><b>Spinal Muscular Atrophy Pipeline is segmented as below:</b><br />Late Stage Candidates (Phase 3)<br />ISIS-SMN Rx<br /><b><br />Early Stage Candidates (Phase 1 and Phase 2)</b><br />Olesoxime (TRO19622)<br />LMI070<br />RO6885247<br />CK-2127107<br />CB.SMN<br />RG3039<br /><b><br />Request For Sample Report:- <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7187">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7187</a></b></div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-48607512378000354652015-10-14T00:04:00.001-07:002015-10-14T00:04:46.884-07:00Chronic Stable Angina Market Upcoming Trends Analysis By 2019<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2Tik4HVOuPzPUaO2p-vm_wL1cWpl5a4NeWRmrC2i2E0HBrmiUvdirBN-C3L_WruhZwu5ZJY8EmoRBR3KBSvlQ3l6gAPpYqc4NQLTQAamRFpOOWzwmx08Q0rQGN6c98b5UhVzSOLMERo5o/s1600/Management_of_chronic_stable_angina.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="259" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2Tik4HVOuPzPUaO2p-vm_wL1cWpl5a4NeWRmrC2i2E0HBrmiUvdirBN-C3L_WruhZwu5ZJY8EmoRBR3KBSvlQ3l6gAPpYqc4NQLTQAamRFpOOWzwmx08Q0rQGN6c98b5UhVzSOLMERo5o/s320/Management_of_chronic_stable_angina.png" width="320" /></a></div>
<br />
Angina is a kind of chest pain or discomfort caused by poor flow of blood in the heart. This often occurs due to narrowing of blood arteries (atherosclerosis) caused by plaque formation or blood clot. People with obesity, history of heart disease, diabetes, high level of blood cholesterol and smoking are high risk of getting affected with angina. Some common symptoms associated with angina include pain, pressure or strange feeling in chest, shortness of breath, lightheadedness, irregular heartbeat, nausea or vomiting and weakness. Angina may be of two types: stable angina and unstable angina. Stable angina is the most common type of angina and is characterized by predictable pattern of chest pain. On the other hand, unstable angina has no typical pattern of chest pain. Stable angina happens when the heart does not get enough oxygen to perform a work which has been asked to do such as exercise or lifting heavy weight which may also occur due to cold weather and emotional stress.<br /><br /><b>Request For Brochure:- <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2214">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2214</a></b><br /><br />Diagnosis of chronic stable angina includes medical history examination by a doctor and few tests such as coronary angiography, coronary risk profile (special blood tests), ECG, exercise tolerance test (stress test or treadmill test), stress echocardiogram and nuclear medicine (thallium) stress test. The treatment options for chronic stable angina include lifestyle changes such as daily exercise and quitting smoking, medications, and procedures such as angioplasty and stent placement and sometimes heart bypass surgery. Most commonly used medications include nitrates, ACE inhibitors and calcium channel blockers. Nicorandil, ranolazine and ivabradine are some of the latest anti-anginal agents which are also used for treating chronic stable angina.<br /><br />The global market for chronic stable angina therapeutics is expected to grow at a moderate CAGR. Some major factors driving the market growth include high prevalence of the disease, extensive research and development of new more effective molecules. According to National Institute for Health and Clinical Excellence, an estimated 2 million people suffered from with stable angina in England in 2010. American Heart Association claims that around 9.1 million people are living with stable angina in the United States. Since stable angina cannot be cured immediately, it is expected that the base population of affected people will increase over the years and such high prevalence will drive market growth particularly in developed countries. The market for chronic stable angina therapeutics is likely to face significant challenges owing to patent expiry of major drugs such as bivalirudin (Angiomax/Angiox) in 2015 in Europe and rosuvastatin (Crestor) in 2016. These patent expiries are expected to attract generic manufacturers who will intensify the competition by selling drugs at low prices.<br /><br />Geographically, North America represents the largest market, followed by Europe, Asia-Pacific and Rest of the World. In Asia-Pacific, rapid urbanization leading to life style changes and emerging economy of key countries such as India and China are expected to drive the market growth. Obesity, stress and cardiovascular diseases have become very common and will drive the market in developing countries significantly. Rapidly evolving medical tourism industry will also play a key role in driving the market growth in the region as a large number of people come from foreign countries to countries like India, Indonesia, Thailand and Singapore for the treatment of chronic stable angina.<br /><br />There are many pharmaceutical companies and research institutes which are engaged in the development, manufacturing and marketing of drugs for treating chronic stable angina. Some major companies and research institutes include Pfizer, Inc., Mylan, Inc., Actavis Inc., Chong Kun Dang Pharmaceutical Corp., Roxane Laboratories, Inc., Gilead Sciences, Inc., CNS, Inc., Nanjing University and King's College London.<br /><br /><b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/chronic-stable-angina-therapeutics-market.html">http://www.transparencymarketresearch.com/chronic-stable-angina-therapeutics-market.html</a></b><br /><br />This research report analyzes this market depending on its market segments, major geographies, and current market trends.<br />
<b>Geographies analyzed under this research report include </b><br />North America <br />Asia Pacific <br />Europe<br />Rest of the World <br /><b><br />This report provides comprehensive analysis of </b><br />Market growth drivers <br />Factors limiting market growth<br />Current market trends <br />Market structure<br />Market projections for upcoming years <br /><br />This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. <br /><b><br />About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><br /><b>Contact Us:-</b><br />Mr. Nachiket<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-23218963649120680032015-08-26T07:06:00.003-07:002015-08-26T07:06:34.438-07:00Nanocapsules Market Segment Forecasts up to 2023<div dir="ltr" style="text-align: left;" trbidi="on">
Nanocapsules are drug delivery agents within the size range of 10nm to 1000 nm that are normally composed of a capsule shell and a hollow space in which desired substance or drug molecules are embedded. The ultrafine size of nanocapsules match the biological composition of human body such as RBCs which permits enhanced permeation and retention (EPR) through narrow channels during diffusion. Due to this EPR effect, nanocapsules are used as drug carriers. Nanocapsules can be formulation using various methods such as loading of drug molecules into hollow polyelectrolyte shell and another method being electrostatic layer by layer (LbL) technique. These latest LbL self-assembled polyelectrolyte capsules provide an efficient way to perform multiple drug delivery tasks simultaneously. Some nanocapsules are used for targeted drug delivery in anti-tumor and anti-tuberculosis therapies wherein the outer sphere of nanocapsules is fabricated by the lithography technique. Lipid nanocapsules (DNA LNCs) and multimodular systems (DNA MMS) are used in gene therapy.<br /><b><br />Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/nanocapsules-market.html">http://www.transparencymarketresearch.com/nanocapsules-market.html</a></b><br /><br />Global investment in nanotechnology research has witnessed a six fold increase during the last decade. Consequently, nanotechnology will completely revolutionize the industrial processes in the near future due to its remarkable economic potential. Some of the key drivers for the market growth include investments and breakthroughs in biomedical, pharmaceutical, electronics, molecular and diagnostic fields. Besides, these nanocapsules are being increasingly used in agrochemicals, environment and wastewater treatments, genetic engineering, consumer goods and cosmetic procedures. Some of the most advanced future applications would be nanocapsule dressings to deliver antibiotics aiding faster wound healing without invasion to the skin. These nanocapsule bandages would be consistently demanded by defence and protection forces as they need not be changed periodically. According to the experts, electronics and magnetic sector will be the largest potential market for nanocapsules, followed by biopharmaceutical industry, catalysis, energy and engineering. However, growth in the nanocapsules market will also pose new challenges with respect to the toxicity and environmental impact of nanocapsules. Recently efforts have been made to overcome these drawbacks by developing eco-friendly versatile nanocapsules. For instance, nanocapsules introduced by the Center for Self-assembly and Complexity, Institute for Basic Science (IBS). Other factors such as cost escalation and consequences on the global economy especially in cases of under-developed economies with poor R&D investment would exhibit low social and ethical acceptance of nanocapsules.<br /><br />Funding for nanotechnology is soaring worldwide at a competitive level, with each major economic power and many developed economies making a substantial investment to revamp their industrial and postindustrial supply chains. Technological inventions and discoveries in nanotechnology would cause tremendous growth in the global nanocapsule market. Due to a variety of potential applications, nanotechnology is expected to become the key technology in the near future. U.S. has invested around USD 3.7 billion through its National Nanotechnology Initiative for research activities. The European Union had spent approximately USD 1.2 billion and Japan USD 750 million by 2012. Moreover, there is a steady demand for medically advanced procedures in developed as well as developing regions having a well-established healthcare infrastructure. In the Asia Pacific region, the demand for nanocapsules is projected to rise owing to the high disease burden of tuberculosis and cancer. Some of the key factors that are likely to contribute toward the market growth are growing awareness about genetic counselling, genetic disorders, high prevalence of tuberculosis and multi-drug resistant tuberculosis, increasing trend in cancer and tumor ailments and surging demand for oncological treatments. <br /><br />Presently, nanocapsules are under different stages of clinical trial phases facing several hurdles to gain market entry. However, few commercially available nanocapsules which are now commercially used as several pigments in sunscreen, scratch resistance coatings, catalysts, and biomarkers. Some of the key market players for these commercially available nanocapsules are Abraxis, Artificial Cell Technologies, Inc., BioDelivery Sciences International, Inc., Biophan Technologies, Inc., Cornerstone Pharmaceuticals, Inc., Genetic Immunity, Inc., Keystone Nano, Inc., Makefield Therapeutics, Inc., Nanospectra Biosciences, Inc., and Mersana Therapeutics, Inc. <br /><br />This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of <br />Market growth drivers <br />Factors limiting market growth<br />Current market trends <br />Market structure<br />Market projections for upcoming years <br /><br />This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. <br /><b><br />Reasons for Buying this Report:-</b><br />
<ul style="text-align: left;">
<li>This report provides pin-point analysis for changing competitive dynamics</li>
<li>It provides a forward looking perspective on different factors driving or restraining market growth </li>
<li>It provides a six-year forecast assessed on the basis of how the market is predicted to grow </li>
<li>It helps in understanding the key product segments and their future</li>
<li>It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors</li>
<li>It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments </li>
<li>It provides distinctive graphics and exemplified SWOT analysis of major market segments</li>
</ul>
<div style="text-align: left;">
<br /><b>Get Sample Report:- <a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5321">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5321</a></b><br /><br /><b>About Us:-</b><br />Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. <br /><b><br />Contact Us:-</b><br />Mr.Nachiket<br />Transparency Market Research<br />State Tower,<br />90 State Street,<br />Suite 700,<br />Albany NY - 12207<br />United States<br />Tel: +1-518-618-1030<br /><b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a><br />Website: <a href="http://www.transparencymarketresearch.com/">http://www.transparencymarketresearch.com</a></b></div>
</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-34556420199021675412015-08-24T07:29:00.001-07:002015-08-24T07:29:17.526-07:00Ischemia Market Segment Forecasts up to 2020<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjICMX-_bMs9xnFPHHM5l-2_u7YY3nRD2IadHz09VfAc3aQtJQxdH9Z-MR-nRh2xBdbN7OKGRzel0rvUeaCORyxm8XDIm05j7XCCRlXgy5rsOMw1kKHWut5ryH3cvbhMELOpvfkTxT_ioy-/s1600/Medical_Devices.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="192" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjICMX-_bMs9xnFPHHM5l-2_u7YY3nRD2IadHz09VfAc3aQtJQxdH9Z-MR-nRh2xBdbN7OKGRzel0rvUeaCORyxm8XDIm05j7XCCRlXgy5rsOMw1kKHWut5ryH3cvbhMELOpvfkTxT_ioy-/s320/Medical_Devices.png" width="320" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Ischemia is characterized by a
specific condition, where there is an insufficient flow of blood supply
to tissues, leading to a shortage of oxygen and glucose which is needed
for cellular metabolism. Due to an obstruction and insufficient blood
supply, various organs and tissue get severely damaged. Ischemia, if
left untreated, may lead to tissue death. Ischemia is primarily caused
by thrombosis of an artery, embolism, vasculitis, atherosclerosis,
coronary artery disease and peripheral artery disease. There are various
types of ischemia with different diagnosis and treatment methods
involved with each type of ischemia. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: left;">
<b>Browse Full Report With TOC:- <a href="http://www.transparencymarketresearch.com/ischemia-market.html">http://www.transparencymarketresearch.com/ischemia-market.html</a></b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>Based on the types, ischemia market can be segmented as follows:</b></div>
<div>
<ul>
<li style="text-align: justify;">Myocardial ischemia: Due to blockage of
a coronary artery, there is a limited blood flow to the heart muscle
and is referred to as myocardial ischemia. Symptoms include arm pain,
chest pain, breathlessness, dizziness, weakness, heart palpitations and
clammy skin.</li>
<li style="text-align: justify;">Cerebral ischemia: Cerebral ischemia
occurs when there is a temporary deficiency of blood supply to an
individual’s brain. Symptoms include difficulty in speaking, lack of
coordination, body movement problems, vision impairment and
unconsciousness.</li>
<li style="text-align: justify;">Intestinal ischemia: Ischemia affects
intestine too, and this condition is known as intestinal ischemia.
Various symptoms include abdominal pain, fever, diarrhea, vomiting,
bloody stools and weight loss.</li>
<li style="text-align: justify;">Hepatic ischemia: In hepatic ischemia,
an individual’s liver does not receive enough blood supply. Hypotension
is the prime cause of hepatic ischemia and symptoms include dehydration,
heart failure, severe bleeding and abnormal heart rhythms. </li>
<li style="text-align: justify;">Acute limb ischemia: Decreased level of
blood flow to hands, feet and legs leads to acute limb ischemia.
Symptoms include skin ulcers, skin sores and severe pain.</li>
</ul>
</div>
<div style="text-align: justify;">
Based on treatment, the ischemia can be segmented as follows:</div>
<ul>
<li>Medications:
<ul>
<li>Angiotensin-converting enzyme (ACE) inhibitors</li>
</ul>
<ul>
<li>Anticoagulants</li>
</ul>
<ul>
<li>Aspirin</li>
</ul>
<ul>
<li>Analgesics</li>
</ul>
<ul>
<li>Beta blockers</li>
</ul>
<ul>
<li>Nitroglycerine</li>
</ul>
</li>
</ul>
<ul>
<li>Surgery methods:
<ul>
<li>Angioplasty, also referred to as percutaneous coronary intervention (PCI)</li>
</ul>
<ul>
<li>Coronary artery bypass surgery</li>
</ul>
<ul>
<li>Embolectomy</li>
</ul>
<ul>
<li>Aortomesenteric bypass and resection of bowel</li>
</ul>
</li>
</ul>
<div style="text-align: justify;">
Based on geography, the ischemia
market can be segmented into four major regions: North America, Europe,
Asia Pacific and Rest of the World (RoW). Out of these regions, North
America dominates the ischemia market followed by Europe. The prime
factors which would drive the growth of the market in these regions are
growing prevalence of high cholesterol diseases, increasing incidences
of obesity and physical inactivity. Moreover, technological advancements
and increasing competition from small market players have further
fueled the growth of ischemia market. According to a survey,
approximately 1.5 million cases of myocardial ischemia occur annually in
the United States. Moreover, technological advancements and increasing
competition from small market players have further fueled the growth of
ischemia market. Asia Pacific is one of the most promising markets for
the growth of ischemia market due to easy market penetration. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The factors which would augment the
growth of the market in Asia Pacific are increasing geriatric
population, high prevalence of unhealthy lifestyle amongst the
population and increasing awareness regarding the malignant effects of
ischemia. Other factors such as tax benefits and increasing disposable
incomes of the population would further propel the growth of ischemia
market.</div>
<div style="text-align: justify;">
<br /></div>
<br />
<div style="text-align: justify;">
Various biopharmaceutical companies
are constantly coming up with novel therapeutics for the treatment of
ischemia. Some of the top players operating in the ischemia market are
Sanofi, Pfizer, Inc., Medicure, Inc., Baxter International, Boston
Scientific Corporation, Vasade Biosciences, Inc. and others.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<div>
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include</div>
<div>
North America</div>
<div>
Asia Pacific</div>
<div>
Europe</div>
<div>
Rest of the World</div>
<div>
<br /></div>
<div>
<b>This report provides comprehensive analysis of</b></div>
<div>
Market growth drivers</div>
<div>
Factors limiting market growth</div>
<div>
Current market trends</div>
<div>
Market structure</div>
<div>
Market projections for upcoming years</div>
<div>
<br /></div>
<div>
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.</div>
<div>
<br /></div>
<div>
<b>Reasons for Buying this Report</b></div>
<div>
This report provides pin-point analysis for changing competitive dynamics</div>
<div>
It provides a forward looking perspective on different factors driving or restraining market growth</div>
<div>
It provides a six-year forecast assessed on the basis of how the market is predicted to grow</div>
<div>
It helps in understanding the key product segments and their future</div>
<div>
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors</div>
<div>
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments</div>
<div>
<b> </b></div>
<div style="text-align: left;">
<b>Get Free Sample Report:-<a href="https://www.blogger.com/goog_373435223"> </a></b><span style="text-align: justify;"><b><u><a href="http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3770">http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3770</a></u></b></span></div>
<div>
<br /></div>
<div>
<b>About Us:-</b></div>
<div>
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.</div>
<div>
<br /></div>
<div>
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.</div>
<div>
<b><br /></b></div>
<div>
<b>Contact Us:-</b></div>
<div>
Mr. Nachiket Ghumare</div>
<div>
90 State Street, Suite 700</div>
<div>
Albany, NY 12207</div>
<div>
Tel: +1-518-618-1030</div>
<div>
USA - Canada Toll Free: 866-552-3453</div>
<div>
<b>Email: <a href="mailto:sales@transparencymarketresearch.com">sales@transparencymarketresearch.com</a></b></div>
<div>
<b>Website:<a href="http://www.transparencymarketresearch.com/"> http://www.transparencymarketresearch.com</a></b></div>
</div>
</div>
Market Research Worldhttp://www.blogger.com/profile/00847761662783664734noreply@blogger.com0tag:blogger.com,1999:blog-3580732351906044807.post-14921498882038328782014-06-17T02:03:00.002-07:002014-06-17T02:03:54.987-07:00Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEioiqrWnjLViyf2Z6i-BEjwc-DmJ29BXx64_01QUzbHk_7KJL4Tt5oVdgbyLAqm8RUMaJsdNPl17KwG8FnAWS3FB5rb435NSMXrLL4nFOnkNPBPasG_pTZXf0tupWS3f0rPpxetaupwl_0/s1600/Neuromodulation+Devices+Market.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEioiqrWnjLViyf2Z6i-BEjwc-DmJ29BXx64_01QUzbHk_7KJL4Tt5oVdgbyLAqm8RUMaJsdNPl17KwG8FnAWS3FB5rb435NSMXrLL4nFOnkNPBPasG_pTZXf0tupWS3f0rPpxetaupwl_0/s1600/Neuromodulation+Devices+Market.jpg" /></a></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
According to a new market report published by Transparency Market Research "Neuromodulation Devices Market - Global Industry Analysis, Size, Share and Forecast, 2012 - 2018 " the global neuromodulation devices market was valued at USD 2,758 million in 2011 and is expected to grow at a CAGR of 14.4% from 2012 to 2018, to reach an estimated value of USD 7,072.6 million by 2018.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse the Neuromodulation Devices Market report with full TOC at </strong><a data-mce-href="http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html" href="http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html">http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The market is driven by factors such as the aging world population leading to chronic diseases such as Parkinson´s and Alzheimer´s disorders and technological advancements in the field of neuromodulation devices including the invention of transversal neuromodulation technology by NMT (Neurowave Medical Technologies). Moreover, the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, the availability of external funding to conduct clinical studies to help come up with new and technologically advanced products and the rising healthcare related consumer expenditure have also driven the growth in this market. The fact that a neuromodulation device could be used as an add-on treatment and so can be used simultaneously with other medications also drives the market forward.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Get Free Sample Report at </strong><a data-mce-href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=627" href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=627">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=627</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The North American region holds majority of the market share and accounted for a share of 65% in 2011. The North American neuromodulation device market was valued at USD 1,792.7 million in 2011. The economic developments in the Asia Pacific region make it the fastest growing region (CAGR of more than 15% from 2012 to 2018) in the neuromodulation devices market.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse all Pharmaceutical Market Research Reports @</strong><a data-mce-href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html" href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html">http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The future growth of the market will be ensured by capitalizing on market opportunities such as increasing healthcare related consumer expenditure in emerging economies in the Asia Pacific, Latin American and Eastern European regions. The availability of medical device manufacturing outsourcing options helps in curbing costs and thereby enhances profit margins. Also, the presence of consolidation options in the healthcare industry helps in strengthening the revenue base to conduct R&D exercises for new product development and thus helps in strengthening market share.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Download PDF at </strong><a data-mce-href="https://tmrresearch.files.wordpress.com/2014/06/neuromodulation-devices-market-global-industry-size-market-share-trends-analysis-and-forecast-2012-2018.pdf" href="https://tmrresearch.files.wordpress.com/2014/06/neuromodulation-devices-market-global-industry-size-market-share-trends-analysis-and-forecast-2012-2018.pdf">Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018</a></div>
</div>
Anonymoushttp://www.blogger.com/profile/17404765961249919111noreply@blogger.com0Albany, NY, USA42.6525793 -73.756231742.4657718 -74.0789552 42.8393868 -73.4335082tag:blogger.com,1999:blog-3580732351906044807.post-39136180413658419862014-06-16T04:27:00.000-07:002014-06-16T04:30:01.582-07:00Nutraceutical Ingredients Market is Expected to Reach USD 29.5 Billion Globally in 2017: Transparency Market Research <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_0_tsilqD67sQNm8czfObSsIYUlj5avKehclIq-iyREMRz3in5BoXqG0NGQilQ-3Xgw46_bHDzzDm3au8J2M6tE0bz7cGNjofTZcuYUrpkXN5LRAA33bN5hwrRZJgP5ANXOUsjU5u1Vw/s1600/Nutraceutical+Ingredients+Market.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi_0_tsilqD67sQNm8czfObSsIYUlj5avKehclIq-iyREMRz3in5BoXqG0NGQilQ-3Xgw46_bHDzzDm3au8J2M6tE0bz7cGNjofTZcuYUrpkXN5LRAA33bN5hwrRZJgP5ANXOUsjU5u1Vw/s1600/Nutraceutical+Ingredients+Market.jpg" height="241" width="320" /></a></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
According to a new market report published by Transparency Market Research "Nutraceutical Ingredients Market - Global Industry Analysis, Market Size, Share, Growth And Forecast 2007 - 2017", global nutraceutical ingredients market is expected to be worth USD 20.8 billion in 2012 and is further expected to reach USD 29.5 billion in 2017, growing at a CAGR of 7.3% from 2012 to 2017. The body building segment is expected to be the largest segment at USD 9.5 billion in 2012. In the overall global market, Asia Pacific region is expected to maintain its lead position in terms of revenue till 2017. Asia Pacific is expected to enjoy 37.5% of global nutraceutical ingredients market revenue share in 2017 followed by North America.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<strong>Browse the Nutraceutical Ingredients Market report with full TOC at</strong><a data-mce-href="http://www.transparencymarketresearch.com/nutraceutical-ingredients-market.html" href="http://www.transparencymarketresearch.com/nutraceutical-ingredients-market.html">http://www.transparencymarketresearch.com/nutraceutical-ingredients-market.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Increasing number of clinical studies confirming the health benefits of nutraceuticals and their broad applications in food, beverages, dietary supplements, and pediatric and adult nutritional preparations has provided support for the growing use of nutraceutical ingredients. Moreover, faster growth in consumption of nutraceutical ingredients worldwide, especially in developing economies has boosted the growth of nutraceutical ingredient market. In addition, increasing economic prosperity in developing countries including India, China, Brazil, Mexico, Russia,South Africa, South Koreaand Poland will enable consumers to spend more on health and nutrition. This will boost the future growth of the nutraceutical ingredient market.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<strong>Get Free Sample Report at </strong><a data-mce-href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=219" href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=219">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=219</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Major segments of nutraceutical ingredients market include Body building, weight control, diabetes control and pain relief. In 2011, body building was the largest segment followed by weight control. The controlling diabetes segment was the third largest segment, accounting for 16.5% revenue share in 2011.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Amino acids and soy-based ingredients segments of body building market witnessed healthy growth rate during the review period (from 2007 to 2011). The growth in amino acid & soy-based ingredient segment is largely attributed to increased trend of fitness in most of the developing nations. The protein and peptide segment is also expected to have steady growth rate because of growing demand for nutritional diet and proper physic all over the world.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<strong>Browse all Pharmaceutical Market Research Reports @</strong> <a data-mce-href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html" href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html">http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Nutraceutical ingredients presents opportunity for new entrants as well for existing players, due to the fact that most of the raw materials are abundant and product manufacturers are increasingly focusing on contract manufacturing outsourcing (CMO). Moreover, large product manufacturers are looking for backward integration, which will grow the competition into the market and will intern increase the market size of the nutraceutical ingredients.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
This report is an effort to identify factors, which will be the driving force behind the nutraceutical ingredient market and its sub-markets over the next six years. The report provides extensive analysis of the nutraceutical industry, current market trends for better understanding of the nutraceutical ingredient market.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<strong>Download PDF at </strong><a data-mce-href="https://tmrresearch.files.wordpress.com/2014/06/nutraceutical-ingredients-market-global-industry-analysis-market-size-share-growth-and-forecast-2007-2017.pdf" href="https://tmrresearch.files.wordpress.com/2014/06/nutraceutical-ingredients-market-global-industry-analysis-market-size-share-growth-and-forecast-2007-2017.pdf">Nutraceutical Ingredients Market - Global Industry Analysis, Market Size, Share, Growth And Forecast 2007 - 2017</a></div>
</div>
Anonymoushttp://www.blogger.com/profile/17404765961249919111noreply@blogger.com0Albany, NY, USA42.6525793 -73.756231742.4657718 -74.0789552 42.8393868 -73.4335082tag:blogger.com,1999:blog-3580732351906044807.post-89175616897685382362014-06-16T02:34:00.000-07:002014-06-16T02:35:03.414-07:00Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019<div dir="ltr" style="text-align: left;" trbidi="on">
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
According to a new market report published by Transparency Market Research, "Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global enteric disease testing market was valued at USD 3.1 billion in 2012 and is expected to grow at a CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6 billion in 2019.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse the full report with complete TOC at </strong><a data-mce-href="http://www.transparencymarketresearch.com/enteric-disease-testing-market.html" href="http://www.transparencymarketresearch.com/enteric-disease-testing-market.html">http://www.transparencymarketresearch.com/enteric-disease-testing-market.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Enteric diseases are major causes of morbidity and mortality worldwide. Developing socio-economic countries with poor drainage, sanitation along with overcrowding and low hygiene awareness account for majority of enteric infection incidences prevailing worldwide. These diseases usually exhibit mild symptoms but if not treated on time can lead to severe complications, resulting in death. In order to manage these diseases effectively, their early detection is essential. Various enteric diseases responsible for diarrhea, stomach pain, nausea, vomiting, anorexia, weight loss and fever are amebiasis, giardiasis, rotavirus infection, salmonellosis and shigellosis.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Get Free Sample Report at </strong><a data-mce-href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258" href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Traditionally, diagnosis of enteric infections relied on culture results of fecal specimen. Today, the world is witnessing a paradigm shift from culture to EIA (enzyme immunoassaya) and PCR (polymerase chain reaction) based tests owing to advantages associated with these newer testing methods. EIA and PCR tests offer enhanced sensitivity and specificity compared to culture tests and also give quick results. Globally the market for enteric disease testing is growing at a CAGR of 2.4% under the influence of rising awareness, demand for point of care testing and increasing application of molecular diagnostics. Use of molecular diagnostic products has made diagnosis easy and possible, even those strains which once seemed to be difficult and impossible. North America and Europe represent the largest regional markets because of rapid demand for molecular based diagnostics and due to high level of awareness among people about the diseases. C.difficile infection is one of the major causes of antibiotic related diarrhea in developed regions.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse all Pharmaceutical Market Research Reports @</strong> <a data-mce-href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html" href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html">http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Various epidemiological sources including CDC and American Association for Clinical Chemistry suggest that C.difficile infection incidence per 100,000 people has increased over the past few decades in United States. In developing nations, frequent travelling to regions where enteric diseases are epidemic is also one of the reasons driving the market growth. Asia-Pacific and Africa have been predicted to grow rapidly during the forecast period. In developing nations of Asia-pacific, Africa and Latin America, the market is also growing due to advent of rapid dipstick tests which can be applied by the patient themself. These regions associated with inadequate healthcare infrastructure do not possess substantial number of laboratories to perform laboratory based tests. Thus, rapid dipstick test kits being inexpensive and easy to use are widely accepted in these regions for managing enteric illness. Continuously improving economy and rising healthcare expenditure in these regions are also anticipated to drive the market. The market is also growing due to emergence of new strains; sources from Eurosurveillance suggest that the norovirus infection is increasing worldwide, including United Kingdom, the Netherlands, France, Japan and Australia due to emergence of new strain of genotype II.4 (GII.4) that is also known as Sydney strain.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Download PDF at </strong><a data-mce-href="https://tmrresearch.files.wordpress.com/2014/06/enteric-disease-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-e28093-2019.pdf" href="https://tmrresearch.files.wordpress.com/2014/06/enteric-disease-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-e28093-2019.pdf">Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019</a></div>
</div>
Anonymoushttp://www.blogger.com/profile/17404765961249919111noreply@blogger.com0Albany, NY, USA42.6525793 -73.756231742.4657718 -74.0789552 42.8393868 -73.4335082tag:blogger.com,1999:blog-3580732351906044807.post-35045901663548825722014-06-16T00:02:00.000-07:002014-06-16T00:03:30.317-07:00Pain Management Therapeutics Market is expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiu9soyWDw_a-D8I_vat0Nww_lrN7z4i3kR_SMzA4DVtji1y-IyHAND7y7EAFjVfzua5LgugwEbBYxPffG1LkoPjuHYhypCVb2OI9Ot5IazRdot50H06Ok9d0aoVSULMuDpypKdUQcol8c/s1600/services-pain-management.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiu9soyWDw_a-D8I_vat0Nww_lrN7z4i3kR_SMzA4DVtji1y-IyHAND7y7EAFjVfzua5LgugwEbBYxPffG1LkoPjuHYhypCVb2OI9Ot5IazRdot50H06Ok9d0aoVSULMuDpypKdUQcol8c/s1600/services-pain-management.jpg" height="298" width="320" /></a></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
According to a new market report published by Transparency Market Research <strong>"</strong>Pain Management Therapeutics Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,<strong>"</strong> in 2011, the global pain management therapeutics market was valued at USD 40.93 billion and is expected to decline at a CAGR of (5.5%) from 2012 to 2018, to reach an estimated value of USD 29.47 billion in 2018.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse the Pain Management Therapeutics Market Research report with full TOC at </strong><a data-mce-href="http://www.transparencymarketresearch.com/pain-management-therapeutics.html" href="http://www.transparencymarketresearch.com/pain-management-therapeutics.html">http://www.transparencymarketresearch.com/pain-management-therapeutics.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The global pain management therapeutics market is expected to experience a decline in revenues at a CAGR of (5.5%) during the forecast period, mainly due to patent expirations of the leading branded drugs. Although the global incidence rates of cancer, diabetes and other debilitating diseases that cause various chronic pain conditions is on a rise, the decline in market revenue is inevitable due to generic incursion for the top pain management drugs. Moreover, lack of a strong pipeline of novel or combination drugs that could help restore the positive growth of the overall market is also expected to contribute to the overall decline in the global pain management therapeutics market.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
Administration of analgesics is the first line of treatment for the management of acute as well as chronic pain conditions. Some of the factors driving the growth of this market include the favorable regulatory and healthcare reforms such as the U.S. Patient Protection and Affordable Care Act of 2010. Also, the economic and effective nature of treatment with therapeutics compared to other modes, such as neurostimulation devices and acupuncture, will continue to fuel the uptake of drugs in pain management.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<strong style="text-align: left;">Get Free Sample Report at </strong><a data-mce-href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059" href="http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059" style="text-align: left;">http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The market for non-steroidal anti-inflammatory drugs (NSAIDs) accounted for the largest share by revenue in 2011, of the total pain management therapeutics market by therapeutic class. This class comprises of some of the oldest known painkillers such as diclofenac, ibuprofen and Aspirin (acetylsalicylic acid) which are now commonly available as over-the-counter (OTC) medications, globally. However, the patent expiry of Celebrex (celecoxib) in 2013 is expected to negatively impact the market with a decline in revenues post patent expiry. The class of other non-narcotic analgesics consists of acetaminophen, sold as OTC drugs in the names of Tylenol, Panadol and Excedrin, and is expected to record the highest CAGR of 3.1% during the forecast period.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<strong>Browse all Pharmaceutical Market Research Reports @</strong><a data-mce-href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html" href="http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html">http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html</a></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
North America was the largest regional market by revenue in 2011, due to the presence of one or more branded drugs belonging to each therapeutic class. However, the region is expected to record the lowest CAGR due to the looming patent expiries of these brands.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
The market for generic formulations accounted for a larger share of the overall pain management therapeutics market in 2011, as against branded formulations. The market for branded pharmaceuticals was highly fragmented in 2011, with Pfizer, Inc., Purdue Pharma LP and Eli Lilly & Co. contributing to over 80% of the total market revenue. Other important players in this market include Endo Health Solutions, AstraZeneca PLC, Johnson & Johnson, and Merck & Co., Inc.</div>
<div data-mce-style="text-align: justify;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: justify;">
<br /></div>
<div data-mce-style="text-align: left;" style="color: #333333; font-family: Georgia, 'Times New Roman', 'Bitstream Charter', Times, serif; font-size: 13px; line-height: 19px; text-align: left;">
<b>Download PDF at: </b><a data-mce-href="https://tmrresearch.files.wordpress.com/2014/06/pain-management-therapeutics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018.pdf" href="https://tmrresearch.files.wordpress.com/2014/06/pain-management-therapeutics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018.pdf">Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018</a></div>
</div>
Anonymoushttp://www.blogger.com/profile/17404765961249919111noreply@blogger.com0Albany, NY, USA42.6525793 -73.756231742.4657718 -74.0789552 42.8393868 -73.4335082